The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial
Cassie Bloy, Ananya Sarma, Bethan Marsh, Lorna Hardy, Meryem Grabski, Merve Mollaahmetoglu, Joshua Shotton, Shamhethan Bhaskaran, Anne Lingford‐hughes, H. Val Curran, Celia Janet Ann Morgan, Will Lawn
Addiction February 16, 2026 DOI: 10.1111/add.70320 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | People with alcohol use disorder |
| Intervention | Intravenous ketamine |
| Dose | 0.8 mg/kg |
| Topics | Addiction Ketamine Esketamine |
| Keywords | Randomized controlled trial Anesthesia Alcohol consumption Clinical trial Poison control Meta-analysis Alcohol dependence |
| Citations | 1 |
| Key findings | Ketamine-related reductions in alcohol consumption do not appear to be mediated by the acute psychoactive effects of ketamine. |
Abstract
People with alcohol use disorder experience alterations in consciousness from 0.8 mg/kg intravenous ketamine administration. Ketamine's effects appear to be broadly consistent across three repeated infusions. Ketamine-related reductions in alcohol consumption do not appear to be mediated by the acute psychoactive effects of ketamine.
Comparable studies
Other randomized controlled trials on ketamine for addiction, most cited first.
Citations in the library
Cites 34
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Mechanisms of Ketamine Action as an Antidepressant Molecular Psychiatry March 13, 2018
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
and 29 more in the library